News

Cheek (the large area of the face on either side) Common issues in the frontal region: sagging and drooping cheek areas, baby fat or excessive fat deposits Precautions for medical aesthetics: parotid gland boundary, course of facial blood vessels Mobile Supermarket Adaptation Project: l Baby fat or excessive fat: Preoperative ultrasound is used to expand the operative visual field, distinguish the boundary between superficial subcutaneous fat and parotid fat, identify deep vascular plexuses, and avoid massive hemorrhage and accidental parotid gland injury during liposuction and lipolysis. Postoperative follow-up ultrasound can serve as the primary examination method. Masseter region (cheek above the mandibular angle) Common midface concerns: enlarged masseter muscles, broad and square facial contours Precautions for Medical Aesthetics: Masseter muscle thickness and boundaries, facial arteries and veins, course of facial nerve Palm Super Adaptation Project: l Masseter hypertrophy: Ultrasound-guided injection of slimming face needle into the planned area, real-time ultrasound monitoring of injection process, and regular ultrasound follow-up of postoperative changes. l Square wide face: Osteotomy and bone grinding surgery for enlarged jawbone, with ultrasound monitoring of postoperative changes Angular oris region and lips Common Periorbital Concerns: Elimination of Oral Commissure Lines (Marionette Lines), Lip Contouring Medical Aesthetic Precautions: Precise Localization of Aberrant Labial Artery Branches and Mental Nerves Ultrasound Palm Probe Suitable Treatments: l Nasolabial folds and marionette lines: Preoperative ultrasound is used to hierarchically identify four layers including the skin, dermis, orbicularis oris muscle and submucosal glands; it accurately locates aberrant branches of the labial artery, facilitating botulinum toxin injection to relax the depressor anguli oris muscle or hyaluronic acid filling of grooves. Postoperative ultrasound assessment serves as the primary examination modality. Autologous fat grafting correction for asymmetric lips: Ultrasound measures the bilateral thickness of the orbicularis oris muscle and subcutaneous spaces, precisely calculating the volume difference for grafting, avoiding blood vessels and glands, and reducing postoperative asymmetry and nodule formation.  

In recent years, the medical aesthetics industry has shifted from extensive and experience-based operations to a refined, visualized and personalized diagnosis and treatment model. Traditional aesthetics medical treatment relies heavily on physicians' visual observation, manual palpation and clinical experience to judge subcutaneous anatomical layers.This model has many inherent limitations: large errors in dermal thickness assessment, low recognition of subcutaneous blood vessels and fascial layers, inability to identify the properties of previously injected fillers, and difficulty in precisely controlling the depth of photoelectric/injection energy therapies.The above problems can easily induce complications such as vascular embolism, facial uneven deformity, nerve damage and unsatisfactory treatment outcomes. In addition the lack of standardized quantitative methods to compare pre-operative and post-operative treatment outcomes has become a core difficulty hindering the safe and standardized implementation of medical aesthetic diagnosis and treatment. High-frequency medical ultrasound boasts core advantages including non-invasive real-time imaging, zero ionizing radiation, convenient bedside operation, and high resolution for soft tissue imaging. It can clearly delineate delicate soft tissue anatomical structures such as the epidermis, dermis, subcutaneous fat, SMAS fascia, superficial blood vessels and tiny facial nerve branches, filling the subcutaneous blind zones invisible to the naked eye and undetectable by manual palpation — yet the lack of its standardized clinical application has become a core obstacle restricting the safe and standardized delivery of aesthetic medical treatment.   Periorbital area (orbital region: upper eyelid, outer canthus, lower eyelid, tear trough) Common Periorbital issues: Upper eyelid wrinkle reduction, crow's feet elimination, under-eye bag contour correction, eyelid reshaping, etc. Medical Aesthetics Precautions: The medial canthus and the medial vascular plexus of the upper eyelid are high-risk areas for injectable treatments Projects Suitable for Palm Ultrasound: u Upper Eyelid Wrinkle Reduction: Under ultrasound guidance, avoid the hazardous vascular plexus at the medial canthus and medial upper eyelid. Administer micro-doses of botulinum toxin to reduce upper eyelid wrinkles, combined with periorbital collagen filler to further improve static fine lines on the upper eyelid. u Dynamic Crow's Feet Elimination: Under ultrasound guidance, inject botulinum toxin to erase dynamic crow's feet at the outer canthus.   Nasal area (nasal bridge, nasal tip, alae nasi, nasal base) Common Nasal Issues: Low nasal bridge and flat radix; enlarged and rounded nasal tip, wide alae; sunken nasal base (the root of nasolabial folds) Medical Aesthetics Precautions: Identify and avoid blood vessels including the dorsal nasal artery, lateral nasal artery, communicating branches of the angular artery, and branches of the facial artery Ultrasound-Guided Applicable Procedures: Low nasal bridge and flat radix u Minimally invasive medium-long term: Visualize tissues via ultrasound, map injection areas, and perform ultrasound-guided hyaluronic acid injection for precise rhinoplasty; Long-term solution: Visualize tissues via ultrasound, map implantation areas, and implant silicone, expanded polytetrafluoroethylene (ePTFE) prostheses or costal cartilage to achieve rhinoplasty outcomes. Postoperative ultrasound evaluation of implantation effects and monitoring of postoperative recovery. u Enlarged and rounded nasal tip, wide alae Visualize tissues via ultrasound, map surgical scopes, and select surgical methods: nasal tip reduction, alar reduction or nasal tip elevation and shaping. u Sunken nasal base (the root of nasolabial folds) Visualize tissues via ultrasound, evade vascular plexuses such as communicating branches of the angular artery, select filling areas and needle entry points, and choose fillers (hyaluronic acid, autologous fat, nasal prostheses) to improve nasal contour. Midface malar region (above the zygomatic bone) Common issues in the midface malar region: descended malar fat pads, hollowness and atrophy, deepened nasolabial folds, soft tissue laxity Medical aesthetics precautions: Blood vessels here communicate with those around the eyes and nasal dorsum, making this the second most frequent site for retrograde facial embolism. In addition, avoid injuring the zygomatic facial nerve Applicable projects for ultrasound-guided aesthetic treatment: u Malar region contouring: Use ultrasound to visualize tissue layers and map out the malar filling area. Under real-time ultrasound guidance, perform hyaluronic acid or autologous fat injection to achieve a plump contouring result.    

In recent years, the medical aesthetics industry has been shifting from extensive and experience-based operations to a refined, visualized and personalized diagnosis and treatment model. Traditional medical aesthetics treatments rely heavily on physicians' visual observation, manual palpation and clinical experience to judge subcutaneous anatomical layers, which come with numerous inherent limitations: substantial errors in dermal thickness assessment, low recognition of subcutaneous blood vessels and fascia layers, inability to identify the properties of previously injected fillers, and difficulty in precisely controlling the depth of energy-based treatments such as photoelectric and injection therapies. These issues can easily trigger complications including vascular embolism, facial uneven deformity, nerve damage and unsatisfactory treatment outcomes. Meanwhile, the lack of standardized quantitative methods to compare pre-operative and post-operative efficacy has become a core bottleneck hindering the safe and standardized implementation of medical aesthetic diagnosis and treatment. High-frequency medical ultrasound boasts core advantages including non-invasive real-time imaging, zero ionizing radiation, convenient bedside operation, and high resolution for soft tissue imaging. It can clearly distinguish delicate soft tissue anatomical structures such as the epidermis, dermis, subcutaneous fat, SMAS fascia, superficial blood vessels, and tiny facial nerve branches, filling the subcutaneous blind spots that cannot be observed by naked eyes or manual palpation. Mainstream high-frequency linear ultrasound probes commonly used in clinical practice (with a standard frequency range of 7–18 MHz) are suitable for superficial soft tissue imaging in medical aesthetics and boast remarkable clinical application value, covering the entire workflow of preoperative assessment, intraoperative guidance and postoperative review: u Preoperative imaging evaluation Accurately measure the thickness of each layer including the skin, subcutaneous fat, fascia and muscles; distinguish true puffy eyes from pseudo soft tissue bulging; identify abnormal tissues such as unknown residual materials from previous injections and subcutaneous cystic nodules. u Intraoperative real-time guidance Dynamically display the course of superficial facial arteries and veins to assist physicians in avoiding blood vessels during puncture; real-time track the depth of needle insertion to fundamentally eliminate the risk of vascular embolism caused by injectables entering the bloodstream. u Postoperative follow-up monitoring Screen for delayed subcutaneous hematoma and filler displacement, continuously monitor local inflammatory responses, and promptly identify postoperative complications.   Frontal region (forehead) Common Forehead Issues: Horizontal forehead lines, transverse lines above glabellar lines, flat depressions, acne scars Medical Aesthetics Precautions: The supraorbital vascular plexus and supratrochlear vascular plexus are absolute avoidance zones for all injection, dissection and energy-based treatments on the forehead. Applicable Projects for Palm Ultrasound: u Dynamic horizontal forehead lines: Inject botulinum toxin under ultrasound guidance while avoiding the supraorbital vascular plexus, extensions of the supratrochlear vascular plexus, nerves and areas where the agent may easily diffuse to non-target muscles to improve dynamic horizontal forehead lines   Glabellar area (glabellar lines) Common glabellar issues: deep glabellar lines, sunken furrows and static wrinkles caused by frowning Medical Aesthetics Precautions:There are two neurovascular foramen, the supraorbital foramen and supratrochlear foramen, plus abundant anastomotic branches of blood vessels along the frontal midline. This area is an absolute avoidance zone for all injections, dissections and energy-based therapies on the frontal region. Projects suitable for palm ultrasound guidance: u Mild dynamic wrinkles: Under ultrasound guidance, precisely inject botulinum toxin while avoiding the supraorbital vascular plexus and the extension of supratrochlear artery to improve mild dynamic wrinkles. u Moderate to severe static depressions: Under ultrasound guidance, combine botulinum toxin with hyaluronic acid filler, or adopt autologous fat grafting to improve moderate to severe static depressions.  

On May 10, the 2026 National BCI Technology & Industrial Innovation Conference opened at Shangri-La Hotel, Gulou District, Nanjing, with the theme "Smart BCI, Forward to the Future". As BCI moves into clinical use, safe skull penetration, accurate nerve regulation and real-time efficacy monitoring are core industry challenges. Wuxi Innosonics relies on high-performance ultrasonic transducers. It builds an integrated diagnosis and treatment system for BCI via ultrasonic energy and imaging, forming a complete care loop for brain diseases. Its advanced technologies won high praise from visitors. Our ultrasonic devices serve as non-invasive precision neuromodulators. Adopting LIFU and HIFU probe technologies, they can safely and reversibly open the blood-brain barrier, delivering drugs to brain lesions and offering new solutions for glioblastoma, Alzheimer’s and other intractable brain disorders. Focused ultrasound modulates neuronal activities to: · Ease headaches, insomnia and other functional nerve issues · Relieve symptoms of Parkinson’s and other neurodegenerative diseases · Correct brain signals as a BCI stimulation tool This realizes non-invasive, precise and reversible brain neuromodulation. Our single-crystal ultra-wideband imaging probe acts as a high-definition detector for BCI. Its mini flexible design penetrates the skull easily and captures high-resolution brain images in real time for accurate target positioning. Combined with AI imaging technology, it can: · Track the opening status of the blood-brain barrier · Monitor cerebral blood flow changes · Detect hemodynamic signals from neuronal activities It provides key data for BCI to interpret brain signals and assess treatment results. Innosonics masters core technologies of high-performance piezoelectric materials and ultra wide-band probes. It addresses key hardware bottlenecks in the BCI sector, delivering all-in-one solutions for imaging monitoring and energy-based treatment. We offer BCI manufacturers the following services: · Custom development of ultrasonic components · Customization of ultrasonic imaging systems · OEM production · Assistance with registration and approval        

Innosonics at CMEFThe 93rd CMEF (China International Medical Equipment Fair), a major global medtech event, was held in full swing at the National Exhibition and Convention Center (Shanghai). Innosonics, a company specializing in ultrasound transducers and minimally invasive interventional imaging technology, made a strong appearance with multiple innovative products, empowering precision medicine through advanced technology and engaging in in-depth exchanges and business discussions with industry partners and experts.         One-Stop Solutions Focused on Three Key DirectionsAt this exhibition, Innosonics focused on three directions - minimally invasive intervention, ultrasound imaging, and multimodal integration - and presented a range of one-stop solutions. 1.Miniature Interventional ImagingInnosonics showcased self-developed, high-performance miniature interventional ultrasound catheters suitable for minimally invasive procedures in cardiology, gastroenterology, urology, and other departments. These products offer high resolution, compact dimensions, and strong biocompatibility, helping enable precise puncture and real-time intraoperative navigation while improving procedural safety and efficiency.2.ICE Intracardiac Ultrasound SolutionThe company also presented a dedicated ICE ultrasound probe and imaging solution that enables high-definition visualization of intracardiac structures. It supports complex procedures such as transseptal puncture, ablation monitoring, and left atrial appendage closure, providing reliable imaging support for electrophysiology and structural heart interventions. 3.Photoacoustic-Ultrasound Multimodal IntegrationAs a forward-looking innovation, the company demonstrated photoacoustic + ultrasound multimodal technology, combining the precision localization advantages of optical methods with the anatomical imaging capabilities of ultrasound. This allows precise lesion identification and clearer boundary delineation, showing unique value in diagnostic and treatment scenarios such as the gastrointestinal and respiratory tracts. 4.Handheld Ultrasound & Patch UltrasoundLightweight handheld ultrasound devices paired with flexible ultrasound patches make imaging more portable and easier to use. These solutions are well suited to point-of-care rapid diagnosis, pre-hospital emergency care, and primary-level screening, helping ultrasound imaging move toward mobility, broader accessibility, and wearable use.     Strong Interest from Domestic and International VisitorsThe booth remained highly active throughout the event. In addition to visitors from across China, overseas buyers from Europe, the United States, Japan, South Korea, India, Indonesia, and other emerging markets came specifically to learn more. In one-to-one discussions with the on-site professional team, they asked detailed questions about product regulatory compliance, core performance, and application fit. Many personally tested the company’s ultrasound devices and experienced the precision diagnostic value brought by high-definition imaging.After these hands-on demonstrations, visitors expressed strong recognition of the equipment’s performance and gave high praise for its image clarity and ease of operation. A number of overseas customers also proactively discussed cooperation details and expressed strong intentions to work together. Meet at CMEF, Talk About the FutureInnosonics continues to uphold the principles of full-stack in-house R&D, import substitution through domestic innovation, and clinical orientation. Supported by capabilities in materials research, precision manufacturing, and system integration, the company provides medical device manufacturers and healthcare institutions with high-performance core components and customized development services.We look forward to working with partners to:• Exchange insights on trends in minimally invasive interventional ultrasound technology• Explore real-world implementation scenarios for handheld ultrasound and photoacoustic integration• Advance product cooperation and joint technology development• Expand domestic and international markets together and upgrade precision medicine Booth Information:Booth No.H3.1ZC04Exhibition Dates:April 9-12, 2026Venue:National Exhibition and Convention Center (Shanghai)The Innosonics professional team and complete technical solutions are ready and waiting for your visit.We look forward to working alongside you to protect life and health through micro-nano innovation and to create new value for the medical industry together.    

Innosonics Showcases at the 2026 ME Supply Chain Ecosystem Expo From March 31 to April 2, 2026, the 10th China Medical Device Supply Chain Ecosystem Conference & Expo (ME Supply Chain Ecosystem Expo) opened grandly at the Shenzhen World Exhibition & Convention Center. As a leading company in core medical ultrasound technologies, Wuxi Innosonics Medical Technology Co., Ltd. made a major appearance with its full range of core ultrasound imaging and ultrasound energy products. With strong technological capabilities and innovative solutions, the company attracted a large number of visitors for on-site discussions, and the booth saw exceptionally strong cooperation interest.      High Booth Traffic, with Hard-Core Technology in the Spotlight At this exhibition, Innosonics centered its display around the theme of "Precision Medicine," showcasing three major product lines: minimally invasive interventional ultrasound transducers, portable handheld ultrasound imaging and patch ultrasound, and ultrasound energy transducers. These offerings covered a wide range of scenarios including clinical diagnosis, minimally invasive treatment, and medical aesthetics. The booth drew a constant stream of visitors from different application fields, many of whom stopped for in-depth discussions on product details and technical advantages.Among the highlights were 6F/8F/10F miniature interventional catheters and their integrated solutions, AI-enabled handheld ultrasound and patch ultrasound solutions, medical aesthetic ultrasound transducers, Sofwave products, and high-performance piezoelectric ceramics. Customers engaged in detailed discussions on product performance, technical specifications, and customized solutions, and gave high recognition to Innosonics’ full-stack in-house R&D capability in ultrasound transducers, its strong capability to replace imported products with locally developed alternatives, and its rigorous quality management system.During the exhibition, the Innosonics team provided one-to-one technical and business consultation for every visitor with professional expertise and detailed explanations. The team received hundreds of potential customer groups on site and reached dozens of preliminary cooperation intentions, covering product distribution, technical customization, supply chain collaboration, and other cooperation models. This fully demonstrated Innosonics’ core competitiveness and market influence in the medical ultrasound sector.    Featured Product Lines• Micro Interventional Probes • Handheld Ultrasound • Patch Ultrasound • Medical Aesthetic Ultrasound • Sofwave • SONAR   Deepening Core Ultrasound Technologies, Empowering Precision Medicine Worldwide As a high-tech enterprise focused on the design, R&D, and manufacturing of ultrasound transducers, Innosonics has consistently adhered to innovation-driven development and has built a complete industrial layout consisting of a "Piezoelectric Smart Materials Factory + Intelligent Transducer Manufacturing Factory + R&D Center."Going forward, Innosonics will continue to focus on core medical ultrasound technologies, break through technical bottlenecks, and empower precision medicine worldwide with better products and services. The company is committed to supporting the upgrading of the medical device supply chain and the progress of import substitution, while striving to become an important global partner in core ultrasound technologies.Innosonics sincerely invites global partners to visit the booth for exchanges and business discussions, explore the future of ultrasound medicine together, and create new industry value hand in hand.  

OverviewOn March 19, KIMES 2026 opened in Seoul, South Korea. Innosonics showcased its latest ultrasound technologies and innovative products at the exhibition, engaging in in-depth exchanges with medical professionals, buyers, and channel partners from around the world.   HighlightsAt KIMES in Seoul, Innosonics showcased a range of flagship products, including high-frequency handheld ultrasound, Patch Ultrasound, medical aesthetic ultrasound transducers, and Sofwave solutions, covering two fast-growing tracks: diagnostic imaging and aesthetic anti-aging.The booth attracted strong traffic, with professional buyers and channel partners from Korea and many other countries visiting to learn more about product performance, application scenarios, and cooperation models. Through professional presentations and live demonstrations, the team fully demonstrated the technical strength of China-developed core ultrasound components, secured a large number of high-quality customer leads, and laid a solid foundation for expanding across Northeast Asia and the global market. Invitation and OutlookWe sincerely invite customers from all sectors to visit Wuxi Innosonics Medical Technology Co., Ltd. for on-site exchanges and first-hand experience of our ultrasound innovations. We also warmly welcome global overseas distributors and partners to discuss cooperation, jointly explore international markets, and help bring high-end ultrasound technology to more users worldwide.Looking ahead, Innosonics will continue to deepen its R&D in ultrasound transducers and core components, drive development through innovation, connect the world through quality, and deliver more high-quality solutions for the medical and aesthetic fields.

Overview On March 19, the International Congress of Cardiovascular and Cerebrovascular Intervention (ICCD) opened in Suzhou. Innosonics showcased its latest ultrasound technologies and innovative products at the event, engaging in in-depth exchanges with medical professionals and industry partners and receiving strong attention and recognition.     HighlightsAt ICCD in Suzhou, Innosonics focused on interventional ultrasound and highlighted one-stop solutions covering interventional probes, photoacoustic-ultrasound fusion technology, and supporting imaging systems.Backed by extensive expertise in miniature interventional probes and photoacoustic composite technology, our solutions are precisely aligned with the needs of minimally invasive cardiovascular and neurovascular diagnosis and treatment. The products’ high resolution, miniaturized design, and end-to-end supporting services were highly recognized by on-site clinical experts and medical device manufacturers, leading to in-depth discussions and targeted business matchmaking. Invitation and OutlookWe sincerely invite customers from all sectors to visit Wuxi Innosonics Medical Technology Co., Ltd. for on-site exchanges and first-hand experience of our ultrasound innovations. We also warmly welcome global overseas distributors and partners to discuss cooperation, jointly explore international markets, and help bring high-end ultrasound technology to more users worldwide.Looking ahead, Innosonics will continue to deepen its R&D in ultrasound transducers and core components, drive development through innovation, connect the world through quality, and deliver more high-quality solutions for the medical and aesthetic fields.

Innosonics is pleased to announce that we will exhibit at KIMES 2026, the leading international medical and hospital equipment exhibition in Korea.   We look forward to meeting partners and customers at COEX, Seoul during March 19–22, 2026.   Visit us at Grand Ballroom G107 to explore our latest innovations.

  On November 30, 2025, the 6th International Conference on Ultrasonic Transducers and Materials was grandly held in Tianjin. It was hosted by the State Key Laboratory of Advanced Medical Materials and Medical Devices, and co-organized by the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Tianjin Institute of Medical and Health Sciences, Chinese Academy of Medical Sciences. As a pivotal academic event in China’s ultrasonic transducer field, this conference brought together experts and scholars from universities, research institutes, hospitals, enterprises and testing institutions both at home and abroad, to jointly discuss the latest advances and future trends in ultrasonic transducer technology. Wuxi Innosonics Medical Technology Co., Ltd. was invited to participate in the conference. The company conducted in-depth exchanges with top domestic and foreign experts, scholars and peer enterprises, showcased its latest achievements in ultrasonic transducer manufacturing technology, and jointly promoted the collaborative innovation and integrated development of the "industry-university-research-hospital" ecosystem.

Wuxi Innosonics Medical Technology Co., Ltd., together with its cooperation partners, showcased its proprietary ICE products at the 21st Medical Creation Fukushima 2025.

From September 24 to 26, the 19th Medtec China 2025 kicked off grandly at Halls 1 & 2 of the Shanghai World Expo Exhibition & Convention Center. On the opening day, the booth of Wuxi Innosonics Medical Technology Co., Ltd. (Booth T301, Hall 2) was thronged with visitors, and the probes & palm ultrasound experience zone was an absolute hit! Customers from home and abroad swarmed to experience the products in person, check the B-mode ultrasound imaging effects, showered praise on our offerings, and conducted in-depth exchanges and technical discussions with our team.